Dunfeng Du
Impact in
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Papers in
- Surgery 9
- Organ Transplantation Techniques and Outcomes 9
-
- Kidney Stones and Urolithiasis Treatments 4
- Co-authors
- Zhishui Chen (18 shared papers)Yuanyuan Zhao (12 shared papers)Jipin Jiang (12 shared papers)Zeyang Li (7 shared papers)Limin Zhang (6 shared papers)Zhonghua Klaus Chen (3 shared papers)Shanshan Chen (4 shared papers)Ping Zhou (6 shared papers)
- Journals
- International Immunopharmacology (4 papers)Transplantation (3 papers)Clinical Kidney Journal (1 paper)International Journal of Medical Sciences (1 paper)Medicine (1 paper)
- Partner nations
- ChinaSaudi ArabiaSouth Korea
In The Last Decade
Dunfeng Du
32 papers receiving 356 citations
Peers
Comparison fields: 5 of 76
- Transplantation 26
- Hepatology 39
- Immunology 102
- Obstetrics and Gynecology 29
- Infectious Diseases 55
Countries citing papers authored by Dunfeng Du
This map shows the geographic impact of Dunfeng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dunfeng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dunfeng Du more than expected).
Fields of papers citing papers by Dunfeng Du
This network shows the impact of papers produced by Dunfeng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dunfeng Du. The network helps show where Dunfeng Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Dunfeng Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 73 | |
| 2 | 2020 | 43 | |
| 3 | 2022 | 24 | |
| 4 | 2022 | 18 | |
| 5 | 2018 | 17 | |
| 6 | 2018 | 17 | |
| 7 | Inhibition of MyD88 by a novel inhibitor reverses two-thirds of the infarct area in myocardial ischemia and reperfusion injury. | 2020 | 17 |
| 8 | 2020 | 14 | |
| 9 | 2018 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2022 | 12 | |
| 12 | 2020 | 12 | |
| 13 | 2024 | 10 | |
| 14 | 2007 | 10 | |
| 15 | 2019 | 8 | |
| 16 | 2019 | 7 | |
| 17 | 2021 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2019 | 6 |
About Dunfeng Du
Dunfeng Du is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Transplantation, Epidemiology and Hepatology, having authored 34 papers that have together received 362 indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (9 papers), Renal Transplantation Outcomes and Treatments (7 papers), Liver Disease and Transplantation (4 papers), Kidney Stones and Urolithiasis Treatments (4 papers), Immune Response and Inflammation (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Hepatitis B Virus Studies (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Transplantation (26 citations), Hepatology (39 citations), Immunology (102 citations), Obstetrics and Gynecology (29 citations) and Infectious Diseases (55 citations). Dunfeng Du has collaborated with scholars based in China, Saudi Arabia and South Korea. Frequent co-authors include Zhishui Chen, Yuanyuan Zhao, Jipin Jiang, Zeyang Li, Limin Zhang, Zhonghua Klaus Chen, Shanshan Chen, Ping Zhou, Toshiro Niki and Fengchao Jiang. Their work appears in journals such as International Immunopharmacology, Transplantation, Clinical Kidney Journal, International Journal of Medical Sciences and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.